Gail Boudreaux - 04 Nov 2022 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Role
President and CEO, Director
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Issuer symbol
ELV
Transactions as of
04 Nov 2022
Net transactions value
$0
Form type
4
Filing time
04 Nov 2022, 17:05:39 UTC
Previous filing
10 Mar 2022
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELV Common Stock Gift $0 -10,000 -8.2% $0.000000 111,415 04 Nov 2022 Direct F1
holding ELV Common Stock 60 04 Nov 2022 Shares Held in Spouse's Revocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Balance includes 252.31 shares acquired on March 25, 2022, 257.62 shares acquired on June 24, 2022 and 266.45 shares acquired on September 23, 2022 through a dividend reinvestment plan.